The FDA is reportedly preparing to force Juul products from the US market

The FDA is reportedly preparing to force Juul products from the US market

Juul Labs Inc.  Peppermint and menthol pods for e-cigarettes are displayed for sale at a store in Princeton, Illinois in September 2019.
in great shape , Juul Labs Inc. Peppermint and menthol pods for e-cigarettes are displayed for sale at a store in Princeton, Illinois in September 2019.


According to a report in the Wall Street Journal, the Food and Drug Administration is reportedly preparing to deny authorization to Juul’s tobacco- and menthol-flavored products, effectively pushing the e-cigarette giant into the U.S. market. has been thrown out.

In its reporting, the Journal cited unidentified people familiar with the matter, who also said the FDA may announce its denial today, Wednesday, June 22.

If the reports are correct, the move comes after an announcement from the FDA on Tuesday that the regulator is working on a plan to establish maximum nicotine levels for cigarettes and other combustible tobacco products. This is a move that aims to make the products less attractive, less addictive and less lethal to the youth.

“Nicotine is powerfully addictive,” FDA Commissioner Robert Calif said in a statement. “The US Surgeon General has reported that 87 percent of adult smokers begin smoking before the age of 18, and that nearly two-thirds of adult daily smokers begin smoking daily by age 18 Nicotine levels have to be reduced to at least addictive or non-addictive levels. There is a possibility that the youth of the future generation may become addicted to cigarettes and the current smokers to quit smoking. Help me.”

Juul has become notorious for its links to youth vaping, skyrocketing to “epidemic” levels in recent years. Health advocates also allege that Juul made its products more potent and addictive, increasing the risk that teens experimenting with vaping would become potentially addicted for life.

A 2019 investigation by the Los Angeles Times found that Juul swiped an idea from RJ Reynolds, the maker of Camel cigarettes, to allow e-cigarette users to take deep drugs without the risk of high levels of nicotine. Nicotine salts and softening chemicals were used. Vomiting or burning in their throat. Health researchers have similarly found that Juul aerosol can deliver significantly more nicotine than other tobacco products. In one study, rodents exposed to Joule aerosol had blood nicotine levels five to eight times higher than those seen after exposure to other e-cigarettes and cigarette products.

vapor epidemic

High nicotine levels are of particular concern because Juul has often been accused of marketing its potent products to underage youth. In 2015 and 2016, the company used young, trendy models in marketing materials, and purchased banner ads on websites reportedly aimed at teenagers and children, including Cartoon Network’s cartoonnetwork.com and Nickelodeon’s sites Nick.com and NickJr. .com included.

In later years, both Juul’s profits and youth vaping grew. Between 2017 and 2018, Juul’s dollar sales grew 783 percent, reaching $942.6 million, according to a Wells Fargo analysis of Nielsen data. And according to the Centers for Disease Control and Prevention, the percentage of middle school students who recently reported e-cigarette use rose from 0.6 percent in 2011 to 10.5 percent in 2019. For high school, utilization increased from 1.5 percent to 27.5 percent over that time frame. ,

As alarm grew over youth vaping trends, Juul announced in 2019 that it would end sales of flavored products popular with youth, such as mango, fruit, crme (creme brlée), and cucumber.

Joule’s CEO Casey Crosthwaite said at the time, “We must reset the vaping category by earning the trust of society and working closely with regulators, policymakers and stakeholders to provide alternatives for adult smokers to reduce the risk of underage smoking.” use can be countered.”

In 2020, the FDA banned sweet and fruity e-cigarette products and began reviewing vaping products, including the rest of Juul’s.

The Wall Street Journal noted that a denial for Juul would also be bad news for Marlboro maker Altria, which in 2018 paid $12.8 billion for a 35 percent stake in Juul. The deal valued Juul at around $35 billion, but its current value has fallen significantly. As of March 31, Altria valued its Juul stake at $1.6 billion.

Leave a Reply